BRK.B
40
7
BEN
57
2
AMGN
38
4
TROW
62
6
SJM
14
2
USB
68
2
PG
43
-2
FOXA
66
2
CAG
34
-2
OI
58
11
CME
52
7
XYL
35
2
MTB
75
2
AAL
57
3
NI
67
2
YUM
58
2
DRI
63
-3
SWK
61
6
LUV
70
2
KMX
38
-9
BRK.B
40
7
BEN
57
2
AMGN
38
4
TROW
62
6
SJM
14
2
USB
68
2
PG
43
-2
FOXA
66
2
CAG
34
-2
OI
58
11
CME
52
7
XYL
35
2
MTB
75
2
AAL
57
3
NI
67
2
YUM
58
2
DRI
63
-3
SWK
61
6
LUV
70
2
KMX
38
-9
Financhill
Back

Petros Pharmaceuticals, Inc. 10K Form

Sell
1

PTPI
Petros Pharmaceuticals, Inc.

Last Price:
$0.0100
Seasonality Move:
20.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PTPI News And Ratings

See the #1 stock for the next 7 days that we like better than PTPI

PTPI Financial Statistics

Sales & Book Value

Annual Sales: $5.1M
Cash Flow: $-1.1M
Price / Cash Flow: 0
Annual Sales: $0.08
Price / Book: 0.15

Profitability

EPS (TTM): -36.57960
Net Income (TTM): $-13.4M
Gross Margin: $1.1M
Return on Equity: -55.57%
Return on Assets: -107.56%

Petros Pharmaceuticals, Inc. Earnings Forecast

Key Petros Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 7 years for PTPI is 20.89%.
  • The Selling, General & Administrative Expenses for PTPI have been equal to 171.15% of Gross Profit Margin.
  • The Research & Development expenses have been 51.15% of Revenue.
  • The Net Earning history of PTPI is -280.10% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

Petros Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: PTPI
CUSIP: 71678J
Website: petrospharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.22
Quick Ratio: 2.2

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PTPI Technical Analysis vs Fundamental Analysis

Sell
1
Petros Pharmaceuticals, Inc. (PTPI) is a Sell

Is Petros Pharmaceuticals, Inc. a Buy or a Sell?